PBC Biomed to lead consortium in development of bone : vimar

PBC Biomed to lead consortium in development of bone adhesive
May 04, 2021 04:00 ET
| Source:
PBC Biomed Ltd
PBC Biomed Ltd
Shannon, IRELAND
SHANNON, Ireland, May 04, 2021 (GLOBE NEWSWIRE) -- PBC Biomed, an Irish-based Medical Device Company, will lead a consortium comprised of Biodesign Europe and SFI Research Centre for Advanced Manufacturing (I-Form) at Dublin City University and Dolmen Design & Innovation, a Dublin-based product design company, in developing a bone adhesive for the treatment of osteoporotic fractures. This partnership was recently awarded €3.4M by the Irish Governments Disruptive Technologies Innovation Fund (DTIF), with an additional €2M investment from the industry partners associated with the project.

Related Keywords

Tennessee , United States , Ireland , Dublin , Dublin City , Irish , Nicholas Dunne , Martin Bruggemann , Gerard Insley , Biodesign Europe , Device Company , Irish Governments Disruptive Technologies Innovation Fund , Irish Based Medical Device Company , Advanced Manufacturing , Dublin City University , Dolmen Design , Chief Scientific Officer , Medical Design Director , Pbc Biomed Ltd , Government Funding , Fracture , Edtech , Disruptive Technology , Research , டென்னசி , ஒன்றுபட்டது மாநிலங்களில் , ஐயர்ல்யாஂட் , டப்ளின் , டப்ளின் நகரம் , ஐரிஷ் , நிக்கோலஸ் டன்னே , சாதனம் நிறுவனம் , டப்ளின் நகரம் பல்கலைக்கழகம் , தலைமை அறிவியல் அதிகாரி , எடெக் ,